InvestorsHub Logo
Followers 198
Posts 13843
Boards Moderated 0
Alias Born 06/10/2013

Re: None

Monday, 02/25/2019 10:01:09 PM

Monday, February 25, 2019 10:01:09 PM

Post# of 4935
**** HEALTHLYNKED DUE DILIGENCE PACKAGE ****

BECOME AN INVESTOR OF A GROUND LEVEL HEALTHCARE STARTUP

Founder, Chairman & CEO Of $1.5 Billion NeoGenomics, Dr. Michael Dent, Now Leading HealthLynked To Even Bigger Growth In New Mushrooming $142 Billion Digital Health Market

https://seekingalpha.com/instablog/21922151-bioresearch-alert/5264370-founder-chairman-and-ceo-1_5-billion-neogenomics-dr-michael-dent-now-leading-healthlynked

Catalysts:
- Recent acquisition puts company annual revenues over $5 million - Cash burn reduced by 50%
- New technology is going to save $50,000 a month on direct costs
- CEO & CFO led NeoGenomics (NASDAQ: NEO) from OTC to NASDAQ
- Company app can reach 880,000 across the United States
- Company expanded their health network to 7,000 hospitals & Acute centers
- Company has over 200,000 subscribers and growing daily


HealthLynked
1726 Medical Blvd
Suite 101
Naples, FL 34110

http://www.healthlynked.com
239-513-1992
investorrelations@healthlynked.com
Ticker: HYLK
OTCQB

Share Structure (Updated: 2-22-19)
Authorized Shares = 500,000,000
Outstanding Shares = 90,182,015
Restricted Shares = 69,102,226
Unrestricted Shares = 21,079,789
Float = 33,125,262

Yahoo Finance: https://finance.yahoo.com/quote/HLYK?p=HLYK
OTC Marketplace: https://www.otcmarkets.com/stock/HLYK/overview
Twitter: https://twitter.com/healthlynked1/with_replies
Facebook: https://www.facebook.com/HealthLynkedONE/
LinkedIn: https://www.linkedin.com/company/healthlynked/
Instagram: https://www.instagram.com/healthlynked/
Pinterest: https://www.pinterest.com/healthlynked/
App Store: https://itunes.apple.com/us/app/healthlynked/id1389786960?mt=8


Company Presentation
https://www.healthlynked.com/records/Investor%20Presentation%201st%20Qtr%202019%20New.pdf

CEO, Dr. Mike Dent Profile
Dr Michael Dent is Chairman and CEO of HealthLynked Corp. Dr. Dent has held key leadership positions in business development, operations, corporate development, and strategy in the healthcare & technology industries since the mid-90s. He was the Founder, former Chairman and CEO of NeoGenomics Laboratories (Nasdaq:NEO), focusing on genetics and cancer diagnostics. Dr. Dent is Co-Founder and Managing Director of InLight Capital Partners LLC and is responsible for Healthcare, Information Technology and Life Science investments. He Serves currently as Chairman of MedOfficeDirect LLC, the largest online distributor of medical supplies direct to physicians and the general public. Dr. Dent received his bachelors from Davidson College, where he majored in both Biology and Pre-Med, he received his Medical Degree from The Medical University of South Carolina in Charleston, SC. and his residency training in Obstetrics and Gynecology at the University of Texas in Galveston, Texas. Dr. Dent Practiced for 20 years, making him uniquely qualified to understand the challenges and opportunities in healthcare and emerging technologies.


CFO, George O'Leary Profile
George G. O'Leary, Chief Financial Officer and Member of the Board of Directors. Mr. O'Leary has served as our Chief Financial Officer since August 6, 2014. He is a financially trained senior executive specializing in innovative strategic problem solving across functional and industry boundaries. Mr. O'Leary is currently the Chairman of the Board of Directors of Timios Holdings Corp. since March 2014 and on the Board of Directors of MedOfficeDirect since October 2013. Mr. O'Leary is founder and President of SKS Consulting of South Florida Corp. ("SKS") since June 2006 where he works with public and private companies in board representation and/or under consulting agreements providing executive level management expertise, as well as helping the implementation and execution of their companies' strategic & operational plans. From 1996 to 2000, Mr. O'Leary was Chief Executive Officer and President of Communication Resources Incorporated ("CRI"), where annual revenues grew from $5 million to $40 million during his tenure. Prior to CRI, Mr. O'Leary was Vice President of Operations of Cablevision Industries, where he ran $125 million of business until it was sold to Time Warner. Mr. O'Leary started his professional career as a senior accountant with Peat Marwick and Mitchell (KPMG). Mr. O'Leary holds a B.B.A. degree in Accounting with honors from Siena College.

Partnerships
https://www.healthlynked.com/partners/


Company News
https://www.otcmarkets.com/stock/HLYK/news








Volume:
Day Range:
Bid:
Ask:
Last Trade Time:
Total Trades:
  • 1D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y
Recent HLYK News